Calling BIEL for June 2010.
PR 4-5-2010: completed audits through 2009
Full reporting company
PR 4-12-2010: seek to move to OTCBB
A/S 1.5 Bil...O/S 1,461,998,871(here's the risk)
FDA filings for reclassification from class III to II devices
Seeking OTC clearance for ActiPatch therapy products
Seeking OTC clearance for Allay menstrual pain relief patch
Estimated FDA response date 6-30-2010
Barring any increase in A/S, I think BIEL could run when they jump to OTCBB, and sometime in June with some positive responses from the FDA. Looks like a good longshot play. I wouldn't expect it to go much under .03 before a FDA response.
